Despite extensive research into MGMT’s role in DNA repair and chemotherapy resistance, a critical integration of how its genetic polymorphisms and epigenetic modifications collectively influence treatment outcomes across cancer types is lacking. The gene discussed is MGMT; the disease is cancer.